Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor

Peptide receptor radionuclide therapy (PRRT) is a relatively new mode of internally targeted radiotherapy currently in clinical trials. In PRRT, ionizing radioisotopes conjugated to somatostatin analogues are targeted to neuroendocrine tumors (NETs) via somatostatin receptors. Despite promising clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yin, Pfeifer, Andreas Klaus, Myschetzky, Rebecca, Garbyal, Rajendra Singh, Rasmussen, Palle, Knigge, Ulrich, Bzorek, Michael, Kristensen, Michael Holmsgaard, Kjaer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665530/
https://www.ncbi.nlm.nih.gov/pubmed/26824927
http://dx.doi.org/10.3390/diagnostics3040344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665530/
https://www.ncbi.nlm.nih.gov/pubmed/26824927
http://dx.doi.org/10.3390/diagnostics3040344

Ejemplares similares